Option chain shows key data for Sartorius's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Sartorius.

Sartorius (OTC:SARTF) Stock, Option Chain

Sartorius

Overview

News

Short Interest

Sartorius AG is a leading provider of bioprocessing solutions. Its bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology. Its laboratory products and services division offers a wide range of products for laboratory use, including scales, pipettes, and filtration equipment. As of 2024, the bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 72% ownership and 83% voting control. The business is geographically diverse, with revenue across Europe, Middle East, and Africa (41% of 2024 sales), the Americas (36%), and Asia-Pacific (23%). We estimate China revenue to be around 10%.

Comments

Sartorius Option Chain

No option chain data available. Please try again later